PHARMALEADS
🏢 View company profile →11Patents
10Active
11Granted
48Portfolio score
Filing activity: Jul 12, 1999 → Feb 11, 2019 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7875436B2 | Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof | Physics | 7 | Active |
| US6324785A | Process for harvesting organic compounds from plant roots | Human Necessities | 4 | Expired |
| US8247608B2 | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8703747B2 | Aminophosphinic derivatives that can be used in the treatment of pain | Emerging Cross-Sectional Technologies | 3 | Active |
| US10131681B2 | Aminophosphinic derivatives that can be used in the treatment of pain | Emerging Cross-Sectional Technologies | 1 | Active |
| US9388129B2 | Mixed inhibitors of aminopeptidase N and neprilysin | Chemistry; Metallurgy | 1 | Active |
| US11648231B2 | Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain | Human Necessities | 0 | Active |
| US10399936B2 | Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt | Chemistry; Metallurgy | 0 | Active |
| US10688113B2 | Methods of treating eye pain with aminophosphinic derivatives | Human Necessities | 0 | Active |
| US11090317B2 | Aminophosphinic derivatives for preventing and treating eye inflammation | Human Necessities | 0 | Active |
| US9272054B2 | Agents for the molecular imaging of serine-protease in human pathologies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.